Ferrari NV vs GeneDx Holdings Corp — how do they compare? Ferrari NV trades at $371.61 (market cap $65.25B), while GeneDx Holdings Corp trades at $61.39 (market cap $1.83B). The key difference: Ferrari NV is far larger — about 35.7× GeneDx Holdings Corp's market cap, and Ferrari NV pays a 1.14% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| RACE | WGS | |
|---|---|---|
Market Cap | $65.25B | $1.83B |
Sector | Consumer Cyclical | Technology |
52-Week High | $517.65 | $167.51 |
52-Week Low | $314.63 | $34.51 |
Enterprise Value | $66.46B | $1.83B |
Dividend Yield | 1.14% | — |
Trailing returns across standard periods
Latest headlines on both assets
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →